scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025

Core Viewpoint - scPharmaceuticals Inc. is set to discuss its financial results for Q4 and full year 2024 during a conference call on March 19, 2025, highlighting its commitment to cardiorenal healthcare innovations [1] Company Overview - scPharmaceuticals is dedicated to revolutionizing cardiorenal healthcare through patient-centric innovations, focusing on advancing care with integrated treatments that address unmet patient needs [3][4] - The company aims to be a leading advocate for patient-centric cardiorenal care, promoting global health improvements through specialized, multidisciplinary approaches [4] Conference Call Details - The conference call will take place at 4:30 p.m. ET on March 19, 2025, and will include a business update alongside the financial results discussion [1] - Registration for the conference call can be completed via a direct link, and the live webcast will be accessible on the company's website [2]